Federal testing for mad cow disease a failure, law review editor says
...ations. But the agency ruled that the BSE test was licensed only for "surveillance" of animal health, and rejected Creekstone's request because it implied "a consumer safety aspect" that was "not scientifically warranted." The agency invoked the 1913 Virus-Serum-Toxin Act, intended to assure the safe supply o...Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
...osure. One group also received three doses of the licensed human anthrax vaccine (anthrax vaccine adsorbed) postexposure. In the group that received ciprofloxacin but no vaccine, only four of nine monkeys, or 44 percent, survived the challenge. The animals remained healthy while on antibiotics but succumbed...Yale technology spins out varicose vein device company: Vascular Insights, LLC
...for a patent on the technology and has exclusively licensed rights to Vascular Insights. "Yale is delighted to bring inventors and entrepreneurs together creating a new business like Vascular Insights in the New Haven area," says Loraine Lombard, manager of the Vascular Insights project for the Office of Coop...Nanoporous 'sponge' removes mercury from offshore produced waters
...d Advanced Materials in Chattanooga, Tenn., is now licensed to commercially produce thiol-SAMMS. SAMMSTM is a registered trademark....Ocean virus identified in human blood samples
...searchers say, that have been developed at OSU and licensed to private industry. "AVI BioPharma has investigated their proprietary NeuGene antisense as an anti-Vesiviral treatment, and is currently conducting further research and development," said Patrick Iversen, a co-author on the study and senior vice pre...PNNL recognized for commercializing technology
...nfection and implant rejection. The technology was licensed in 2004 to Bacterin, of Belgrade, Mont., and is ready for commercial application. Bacterin is a medical device testing facility for medical implant manufacturers and has FDA approval for applying the thin-film coating to medical devices for orthopedi...BiovaxID produces long term clinical remission and 95 percent overall survival
...igen produced in a hybridoma cell line exclusively licensed from Stanford University. Other vaccines currently being evaluated for the treatment of follicular lymphoma are made by molecular cloning and splicing, and incorporate only a portion of the patient's tumor antigen. Background on immunotherapeutics f...Electronic nose could spell the end of landfill pongs
...f in landfill sites. There are currently over 4000 licensed sites in the UK. Eighty per cent of the population live within 2km of a site. Methane gas and odours, which contribute to global warming, are produced by decomposing waste. Currently there is no other instrumentation sensitive enough to monitor low c...FDA approves first medical device using Rutgers biomaterial
...de range of medical implant applications. TyRx has licensed this entire library of polyarylates from Rutgers and has now, as a first application, identified one of these polymers for the hernia repair device. The New Jersey Center for Biomaterials, based at Rutgers, is a cooperative research initiative spons...University of Chicago researchers have licensed a genetic test that determines which patients are likely to have a serious adverse reaction to irinotecan hydrochloride (Camptosar), a key component of the standard first-line treatment for advanced cancers of the colon and rectum, to Mayo Clinic. Un...Accentia Biopharmaceuticals announces option agreement with Mayo
...ce with the Bayh-Dole Act of 1980, Mayo Clinic has licensed technology for the treatment of chronic rhinosinusitis with antifungals to Accentia and will receive royalties from the license....Toxicology-on-a-chip tool readies for market
...nstitute and University of California-Berkeley and licensed exclusively to Solidus Biosciences. The MetaChip uses a culturing method by combining enzyme catalysis with cell-based screening on a single microscale chip. The drug candidates are added to a chip containing approximately 2,000 combinations of the e...AutovaxID-C introduced by Accentia Biopharmaceuticals
...usitis). SinuNase was originally developed by and licensed from the Mayo Foundation for Medical Education and Research. BiovaxID TM is a patient-specific anti-cancer vaccine intended for the treatment of follicular non-Hodgkin's lymphoma. BiovaxID is being developed by Accentia's subsidiary Biovest Intern......s prevalent world-wide, and no other country has a licensed vaccine. "The public is being sold out. CSL used to be publicly-owned, like Telstra, but now it's privately-owned they have lost any sense of obligation to the Australian community. The government needs to take urgent action to ensure the vaccine re...New antibody shows promise as cure for anthrax
...xin and remove it from the body. This antibody was licensed to Elusys Theraputics, a New Jersey-based biopharmaceutical company, who turned it into a full immunoglobulin G (IgG). In trials, Elusys has found that the IgG protects test animals from anthrax when administered both before and after exposure to the...Innovative research set to push boundaries of cancer care
...the animals. This compound, now called RTA744, was licensed by Reata Pharmaceuticals in Dallas and is undergoing phase I studies at the M. D. Anderson Cancer Center. The researchers say the agent may prove to be effective in treating brain tumor patients because, in contrast to doxorubicin, it can cross the b......date CD CII (methylphenidate HCl, USP). Zyrtec is licensed to and co-promoted with Pfizer, Inc. in the United States. For further information: Lisa B. Garman Susan Thiele Head, U.S. Communications & Public Relations Ketchum Public Relations Mobile phone: +1 404.291.4772 Phone: +1 646.935.4133 susan.thiel...Vaginal gel may provide a new approach to HIV prevention
...arks the first time any pharmaceutical company has licensed an anti-HIV compound for development as a microbicide when the class of drugs is so early in development. Women make up nearly half of all people living with HIV worldwide, and 80 percent of new cases of HIV infection in women result from heterosexua...New imaging method shows early in treatment if brain cancer therapy is effective
... a patent on this MRI diffusion technology and has licensed the commercialization rights to Molecular Therapeutics of Ann Arbor, in which Ross and Rehemtulla have a financial interest. A diffusion MRI can be performed on a standard MRI machine using a special workstation to compute the diffusion map. A workst...Three ORNL technologies earn technology transfer excellence awards
...etain their native chemical activity. The slide is licensed to Diversified Biotech of Boston, which is working...by DOE's Office of International Safeguards and is licensed to Canberra Aquila of Albuquerque, N.M. Researchers working on the project are Peter Chiaro, Curt Ma...